JP7022126B2 - 合成のラクダ臓器抽出物、その製造方法およびその使用 - Google Patents
合成のラクダ臓器抽出物、その製造方法およびその使用 Download PDFInfo
- Publication number
- JP7022126B2 JP7022126B2 JP2019522946A JP2019522946A JP7022126B2 JP 7022126 B2 JP7022126 B2 JP 7022126B2 JP 2019522946 A JP2019522946 A JP 2019522946A JP 2019522946 A JP2019522946 A JP 2019522946A JP 7022126 B2 JP7022126 B2 JP 7022126B2
- Authority
- JP
- Japan
- Prior art keywords
- camel
- acid
- organ
- synthetic
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Birds (AREA)
- Heart & Thoracic Surgery (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01466/16 | 2016-11-04 | ||
CH01466/16A CH713107B1 (de) | 2016-11-04 | 2016-11-04 | Synthetische Kamel-Organ-Extrakte, Verfahren zu ihrer Herstellung und ihre Verwendung. |
PCT/EP2016/079098 WO2018082795A1 (de) | 2016-11-04 | 2016-11-29 | Synthetische kamel-organ-extrakte, verfahren zu ihrer herstellung und ihre verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019532987A JP2019532987A (ja) | 2019-11-14 |
JP7022126B2 true JP7022126B2 (ja) | 2022-02-17 |
Family
ID=57442680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019522946A Active JP7022126B2 (ja) | 2016-11-04 | 2016-11-29 | 合成のラクダ臓器抽出物、その製造方法およびその使用 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7022126B2 (de) |
CH (1) | CH713107B1 (de) |
DE (1) | DE112016007409A5 (de) |
WO (1) | WO2018082795A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112675159A (zh) * | 2021-01-12 | 2021-04-20 | 杭州师范大学 | L-苹果酸在制备防治肝脏缺血再灌注损伤药物中的应用 |
CN113908174B (zh) * | 2021-10-29 | 2022-06-24 | 北京四环制药有限公司 | 一种高效安全的脑蛋白水解物制备方法及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59208894D1 (de) * | 1991-12-02 | 1997-10-16 | Riemschneider Randolph Prof Dr | Wässrige synthetische Organextrakte |
-
2016
- 2016-11-04 CH CH01466/16A patent/CH713107B1/de unknown
- 2016-11-29 DE DE112016007409.3T patent/DE112016007409A5/de not_active Withdrawn
- 2016-11-29 JP JP2019522946A patent/JP7022126B2/ja active Active
- 2016-11-29 WO PCT/EP2016/079098 patent/WO2018082795A1/de active Application Filing
Non-Patent Citations (1)
Title |
---|
Camel in Chemistry II Camel Placenta Extracts, [online], 2016-AUG-01 uploaded, The Pellam Journal of Science, [Retrieved on 2020-OCT-19], Retrieved from the internet:<URL:http://www.bwwsociety.org/journal/science/archive/2016-07/camelii/Camel%20in%20Chemistry%20II.htm>&<http://www.bwwsociety.org/journal/science/archive/2016-07/editorsletter/Journal%20of%20Science%20Editor's%20Letter.htm> |
Also Published As
Publication number | Publication date |
---|---|
WO2018082795A1 (de) | 2018-05-11 |
DE112016007409A5 (de) | 2019-08-01 |
JP2019532987A (ja) | 2019-11-14 |
CH713107A2 (de) | 2018-05-15 |
CH713107B1 (de) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5905188B2 (ja) | シアル酸並びにegfおよび/またはfgfを含有する化粧料または育毛剤およびこれらの製造方法 | |
JP5635226B2 (ja) | 毛乳頭細胞増殖促進剤 | |
JP2009234980A (ja) | 細胞成長因子類にノイラミン酸類、プラセンタを配合してなる美容組成物 | |
IL157814A (en) | Cosmetic composition comprising camel milk or components thereof | |
TW542829B (en) | Acyl derivatives of glycosyl-L-ascorbic acid | |
KR20120015317A (ko) | 개선된 콜라겐 분산물 및 이의 제조 방법 | |
JP7022126B2 (ja) | 合成のラクダ臓器抽出物、その製造方法およびその使用 | |
CN107375007B (zh) | 一种护肤品组合物、氨基酸皂及其制备方法 | |
CN105682481A (zh) | 包含胆碱及其衍生物的组合物、其用途以及其制备方法 | |
US10610537B2 (en) | Methods of producing sialooligosaccharides and uses thereof | |
JP2000327525A (ja) | 皮膚外用剤 | |
Hroshovyi et al. | DRONE BROOD–AS A RAW MATERIAL FOR THE MANUFACTURE OF MEDICINES AND DIETARY SUPPLEMENTS. | |
JP3413220B2 (ja) | 肌荒れ改善剤 | |
JPH10175868A (ja) | 津液改善組成物 | |
CN108066364A (zh) | 合成的骆驼器官提取物、其制备方法及其应用 | |
RU2536296C2 (ru) | Биологически активная добавка к пище | |
JP2021187787A (ja) | エクソソーム分泌促進剤、エクソソーム取り込み促進剤、エクソソーム分泌促進用美容組成物、及びエクソソーム分泌促進方法 | |
JPS5888317A (ja) | 無脊椎海棲動物から抽出した製品及びその調整法 | |
JPH03167113A (ja) | 養毛剤 | |
JP5642924B2 (ja) | 皮膚バリア機能回復促進用水中油型乳化組成物 | |
JP3172599B2 (ja) | 細胞賦活剤 | |
RU2363481C1 (ru) | Способ производства пантогематогена | |
JPH09176030A (ja) | 皮脂分泌促進剤 | |
JPS6233111A (ja) | 養毛組成物 | |
Joyce | 5-hydroxytryptamine content of glioma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190507 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191031 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201027 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210608 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210906 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220118 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220204 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7022126 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |